Kelly Doyle

1.3k total citations
38 papers, 476 citations indexed

About

Kelly Doyle is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Kelly Doyle has authored 38 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Physiology. Recurrent topics in Kelly Doyle's work include Clinical Laboratory Practices and Quality Control (4 papers), Chronic Kidney Disease and Diabetes (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). Kelly Doyle is often cited by papers focused on Clinical Laboratory Practices and Quality Control (4 papers), Chronic Kidney Disease and Diabetes (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). Kelly Doyle collaborates with scholars based in United States, Tanzania and United Kingdom. Kelly Doyle's co-authors include F.A. Fitzpatrick, Dustin R. Bunch, Kamisha L. Johnson‐Davis, Kornelia Edes, Philip J. Moos, F.A. Fitzpatrick, Marilyn A. Huestis, Melanie L. Lewis Ivey, Murali Gopalakrishnan and M. Mwangi and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Kelly Doyle

32 papers receiving 463 citations

Peers

Kelly Doyle
Sherif Y. Saad Saudi Arabia
Shujue Li China
Jon D. Gower United Kingdom
Sherif Y. Saad Saudi Arabia
Kelly Doyle
Citations per year, relative to Kelly Doyle Kelly Doyle (= 1×) peers Sherif Y. Saad

Countries citing papers authored by Kelly Doyle

Since Specialization
Citations

This map shows the geographic impact of Kelly Doyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Doyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Doyle more than expected).

Fields of papers citing papers by Kelly Doyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Doyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Doyle. The network helps show where Kelly Doyle may publish in the future.

Co-authorship network of co-authors of Kelly Doyle

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Doyle. A scholar is included among the top collaborators of Kelly Doyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Doyle. Kelly Doyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bahr, Timothy M., Kelly Doyle, Robin K. Ohls, & Robert D. Christensen. (2025). Using the refineR algorithm to generate indirect reference intervals for newborn infants for the parameters “Micro-R” and “HYPO-He”. Journal of Perinatology. 45(11). 1624–1626.
2.
Doyle, Kelly, et al.. (2025). TSH Receptor Antibody Test Utilization Patterns From a National Reference Laboratory: TRAb, TSI, or Both?. The Journal of Clinical Endocrinology & Metabolism. 111(1). e92–e99. 1 indexed citations
3.
Doyle, Kelly, Julie J. Purkal, Cara L. Hrusch, et al.. (2025). Targeting tumor intrinsic TAK1 engages TNF-α-driven cell death through distinct mechanisms and enhances cancer immunotherapy. Cell Death and Disease. 16(1). 725–725.
4.
Doyle, Kelly, et al.. (2024). Analytical and operational considerations of measuring glucose 6-phosphate dehydrogenase (G6PD) activity using a fully automated assay. American Journal of Clinical Pathology. 163(1). 153–160.
5.
Pearson, L., et al.. (2023). A-163 Abnormal HbA1c Results Lead to an Unexpected Chronic Myeloid Leukemia Diagnosis. Clinical Chemistry. 69(Supplement_1). 1 indexed citations
6.
Pearson, L., et al.. (2023). Abnormal Hb A1c Result from a Diabetic Patient Leads to Unexpected Diagnosis.. PubMed. 69(7). 684–687. 1 indexed citations
7.
Doyle, Kelly & Dustin R. Bunch. (2023). Reference intervals: past, present, and future. Critical Reviews in Clinical Laboratory Sciences. 60(6). 466–482. 17 indexed citations
8.
Genzen, Jonathan R., et al.. (2022). Comparison of two chromogranin A assays and investigation of nonlinear specimens. Practical Laboratory Medicine. 32. e00299–e00299. 2 indexed citations
9.
Doyle, Kelly & Elizabeth L. Frank. (2021). Verifying Clinically Derived Reference Intervals for Daily Excretion Rates of Fractionated Metanephrines Using Modern Indirect Reference Interval Models. American Journal of Clinical Pathology. 156(4). 691–699. 3 indexed citations
10.
Johnson‐Davis, Kamisha L., et al.. (2020). Cannabinol (CBN) Cross-Reacts with Two Urine Immunoassays Designed to Detect Tetrahydrocannabinol (THC) Metabolite. The Journal of Applied Laboratory Medicine. 5(3). 569–574. 4 indexed citations
11.
Bahr, Timothy M., Robert D. Christensen, Diane M. Ward, et al.. (2019). Ferritin in serum and urine: A pilot study. Blood Cells Molecules and Diseases. 76. 59–62. 20 indexed citations
12.
Johnson‐Davis, Kamisha L. & Kelly Doyle. (2019). Therapeutic Drug Monitoring in Pregnant Patients. Therapeutic Drug Monitoring. 42(2). 172–180. 5 indexed citations
13.
Doyle, Kelly, et al.. (2018). Evaluation of a new venous catheter blood draw device and its impact on specimen hemolysis rates. Practical Laboratory Medicine. 10. 38–43. 8 indexed citations
14.
Doyle, Kelly. (2018). Parkin Function in Parkinson Disease. Clinical Chemistry. 64(11). 1676–1676. 1 indexed citations
15.
Mali, Raghuveer Singh, Elisabeth A. Lasater, Kelly Doyle, et al.. (2017). FLT3-ITD Activation Mediates Resistance to the BCL-2 Selective Antagonist, Venetoclax, in FLT3-ITD Mutant AML Models. Blood. 130. 1348–1348. 17 indexed citations
16.
Zhu, Chang, Sujatha M. Gopalakrishnan, Kelly Doyle, et al.. (2016). A-306989, an inhibitor of adenosine kinase, is renoprotective in rodent models of podocyte, basement membrane, and obstructive injury. European Journal of Pharmacology. 788. 1–11. 6 indexed citations
17.
Doyle, Kelly & Frederick G. Strathmann. (2016). Cost and Efficacy Assessment of an Alternative Medication Compliance Urine Drug Testing Strategy. Pain Medicine. 18(2). 307–315. 5 indexed citations
18.
Marin, Stephanie J., et al.. (2015). One Hundred False-Positive Amphetamine Specimens Characterized by Liquid Chromatography Time-of-Flight Mass Spectrometry. Journal of Analytical Toxicology. 40(1). bkv101–bkv101. 25 indexed citations
19.
Doyle, Kelly & F.A. Fitzpatrick. (2010). Redox Signaling, Alkylation (Carbonylation) of Conserved Cysteines Inactivates Class I Histone Deacetylases 1, 2, and 3 and Antagonizes Their Transcriptional Repressor Function. Journal of Biological Chemistry. 285(23). 17417–17424. 128 indexed citations
20.
Makowska-Grzyska, M., et al.. (2005). Structural, Spectroscopic, and Reactivity Properties of N2S2(thioether)‐O(amide)‐Ligated HgII Complexes: The First Examples of HgII‐Mediated Amide Cleavage. European Journal of Inorganic Chemistry. 2005(5). 822–827. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026